EUVIMEDEUVIMED entdecken
VergleichsstudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cells

Rosaria Greco iD, Federico Bighiani, Chiara Demartini iD, Annamaria Zanaboni, Miriam Francavilla, Sara Facchetti, Daisy Sproviero, Gloria Vaghi iD, Marta Allena, Daniele Martinelli iD, Michele Corrado, Elena Guaschino und 8 weitere

Cephalalgia · 2025

DOI: 10.1177/03331024251386769 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cephalalgia, 2025. Verfasst von Rosaria Greco und 19 weiteren Autor:innen. Beteiligte Einrichtung: Headache Science & Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy. Hauptthemen laut MEDLINE: Leukocytes, Mononuclear, MicroRNAs, Migraine Disorders, Monocytes. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Emerging evidence highlights the role of microRNAs (miRNAs) in epigenetic mechanisms related to migraine pain. The expression of miR-382-5p and miR-34a is higher in serum and peripheral blood mononuclear cells of people with migraine, but limited data is available regarding their possible alteration in other cell subtypes. Several lines of evidence support a monocyte dysfunction in migraine pathophysiology. To gain deeper insights into cell-specific miRNAs expression in migraine individuals with different disease severity, this study aims to determine the expression levels of miR-34a and miR-382-5p in monocytes.

Methods

This cross-sectional, controlled study included 47 participants with episodic migraine (EM, 72.3% females, 41.4 ± 10.7 years), 32 with chronic migraine with medication overuse (CM-MO, 81.3% females, 46.1 ± 10.9 years) and 30 healthy controls (HCs, 66.7% females, 42.9 ± 14.8 years). We assessed interictal monocyte-specific miR-382-5p and miR-34a expression by qRT-PCR, normalizing the expression with U6 RNA (relative quantification - RQ). Results miR-382-5p monocytic expression was higher in EM (4.21 ± 1.41 RQ) and CM-MO (6.80 ± 4.37 RQ) when compared to HCs (2.02 ± 0.64 RQ) ( p = 0.005 for all comparisons). miR-34a monocytic expression was higher in EM (4.50 ± 1.62 RQ) and CM-MO (6.47 ± 1.87 RQ) when compared to HCs (1.94 ± 0.81 RQ, p = 0.005 for all comparisons). Expression of miR-382-5p and miR-34a were higher in CM-MO when compared to EM ( p = 0.005 for both comparisons). After adjusting for age, sex, ongoing preventive medications, presence of anxiety or depressive symptoms, and smoking habit, a logistic regression model confirmed the differences in the monocytic expression of miR-34a and miR-382-5p between EM and CM-MO participants.

Conclusions

Our findings underscore the relevance of miR-34a and miR-382-5p in migraine pathophysiology, as evidenced by their altered expression in monocytes from migraine participants compared to HCs. These miRNAs were also associated with disease severity, being higher in CM-MO when compared to EM individuals. Trial Registration The study protocol was registered at ClinicalTrials.gov (NCT05891808)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukocytes, MononuclearMicroRNAsMigraine DisordersMonocytesAdultFemaleHumansMaleMiddle AgedCross-Sectional Studies

Stichwörter der Autor:innen

PBMCsepigeneticheadachemicroRNAspain

Substanzen

MicroRNAsMIRN34 microRNA, human

Autor:innen und Institutionen

  • Headache Science & Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy.
  • Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.

ORCID-Profile: Rosaria Greco, Chiara Demartini, Gloria Vaghi, Daniele Martinelli, Sara Bottiroli, Alessandro Antoniazzi, Cristina Tassorelli, Roberto De Icco

Förderung

  • Ministero della Salute

Zitieren

APA

Greco, R., Bighiani, F., Demartini, C., Zanaboni, A., Francavilla, M., Facchetti, S., Sproviero, D., Vaghi, G., Allena, M., Martinelli, D., Corrado, M., Guaschino, E., Ghiotto, N., Bottiroli, S., Cammarota, F., Antoniazzi, A., Grillo, V., Sances, G., Tassorelli, C., & De Icco, R. (2025). miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cells. Cephalalgia. https://doi.org/10.1177/03331024251386769

Vancouver

Greco R, Bighiani F, Demartini C, Zanaboni A, Francavilla M, Facchetti S, et al. miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cells. Cephalalgia. 2025. doi:10.1177/03331024251386769

BibTeX
@article{Greco2025,
  author = {Greco, Rosaria and Bighiani, Federico and Demartini, Chiara and Zanaboni, Annamaria and Francavilla, Miriam and Facchetti, Sara and Sproviero, Daisy and Vaghi, Gloria and Allena, Marta and Martinelli, Daniele and Corrado, Michele and Guaschino, Elena and Ghiotto, Natascia and Bottiroli, Sara and Cammarota, Francescantonio and Antoniazzi, Alessandro and Grillo, Valentina and Sances, Grazia and Tassorelli, Cristina and De Icco, Roberto},
  title = {miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cells},
  journal = {Cephalalgia},
  year = {2025},
  doi = {10.1177/03331024251386769}
}
Kostenlos starten →